ID19492A - Penggunaan l-deprenil untuk memperlambat penurunan fungsi sistem imun yang bergantung pada umur - Google Patents

Penggunaan l-deprenil untuk memperlambat penurunan fungsi sistem imun yang bergantung pada umur

Info

Publication number
ID19492A
ID19492A IDP971252A ID971252A ID19492A ID 19492 A ID19492 A ID 19492A ID P971252 A IDP971252 A ID P971252A ID 971252 A ID971252 A ID 971252A ID 19492 A ID19492 A ID 19492A
Authority
ID
Indonesia
Prior art keywords
deprenil
age
function
slow down
system depending
Prior art date
Application number
IDP971252A
Other languages
English (en)
Inventor
Norton W Milgram
David R Stevens
Gwendolyn O Ivy
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID19492(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of ID19492A publication Critical patent/ID19492A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Thin Film Transistor (AREA)
  • Pulse Circuits (AREA)
  • Electrotherapy Devices (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
IDP971252A 1990-08-31 1997-04-15 Penggunaan l-deprenil untuk memperlambat penurunan fungsi sistem imun yang bergantung pada umur ID19492A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (1)

Publication Number Publication Date
ID19492A true ID19492A (id) 1998-07-16

Family

ID=27076843

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971252A ID19492A (id) 1990-08-31 1997-04-15 Penggunaan l-deprenil untuk memperlambat penurunan fungsi sistem imun yang bergantung pada umur

Country Status (15)

Country Link
US (2) US5276057A (id)
EP (2) EP0732101B1 (id)
JP (3) JP2819072B2 (id)
AT (2) ATE149350T1 (id)
AU (1) AU633714B2 (id)
BR (1) BR9103506A (id)
CA (1) CA2039194C (id)
DE (2) DE69124875T2 (id)
DK (2) DK0473252T3 (id)
ES (2) ES2135123T3 (id)
GR (2) GR3022971T3 (id)
ID (1) ID19492A (id)
MX (1) MX9100067A (id)
MY (2) MY124210A (id)
NZ (1) NZ238277A (id)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
WO1992017169A1 (en) * 1991-04-04 1992-10-15 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
EP0623344B1 (fr) * 1993-05-04 2000-07-26 Ceva Sante Animale Utilisation de la Sélégiline en médecine vetérinaire
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
HU223475B1 (hu) * 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
FI972988L (fi) 1995-01-13 1997-09-11 Somerset Pharmaceuticals Inc Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
WO1996024346A1 (en) * 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2236368C (en) * 1995-11-06 2001-10-23 Somerset Pharmaceuticals, Inc. Sublingual and buccal administration of selegiline
BR9908713A (pt) 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
AU2003282337B2 (en) * 2002-11-07 2009-07-16 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
EP1622450A4 (en) * 2003-04-25 2009-11-18 Endo Pharmaceuticals Solutions PROCESS FOR PROMOTING UNINTERRUPTED SLEEP BY ADMINISTERING TROPIUM CHLORIDE
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
EP1686973A4 (en) * 2003-11-25 2009-03-25 Technion Res & Dev Foundation COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
US8999375B2 (en) * 2009-12-29 2015-04-07 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
CN102791258B (zh) 2010-02-03 2018-05-08 图必制药公司 雷沙吉兰的延长释放制剂及其用途
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
DE69131386T2 (de) 1999-11-25
GR3031263T3 (en) 1999-12-31
EP0473252A3 (en) 1992-08-05
JPH09328422A (ja) 1997-12-22
DK0473252T3 (da) 1997-09-15
JPH09328423A (ja) 1997-12-22
US5387615A (en) 1995-02-07
HK1011611A1 (en) 1999-07-16
EP0473252B1 (en) 1997-03-05
JP2884501B2 (ja) 1999-04-19
JP2819072B2 (ja) 1998-10-30
ES2097790T3 (es) 1997-04-16
MX9100067A (es) 1992-04-01
EP0732101B1 (en) 1999-06-23
CA2039194C (en) 1997-01-28
NZ238277A (en) 1993-10-26
ATE181501T1 (de) 1999-07-15
AU633714B2 (en) 1993-02-04
CA2039194A1 (en) 1992-03-01
EP0473252A2 (en) 1992-03-04
ES2135123T3 (es) 1999-10-16
DK0732101T3 (da) 1999-11-22
JP2884500B2 (ja) 1999-04-19
DE69131386D1 (de) 1999-07-29
ATE149350T1 (de) 1997-03-15
US5276057A (en) 1994-01-04
MY124210A (en) 2006-06-30
GR3022971T3 (en) 1997-06-30
JPH04230624A (ja) 1992-08-19
DE69124875D1 (de) 1997-04-10
BR9103506A (pt) 1992-05-12
AU7395791A (en) 1992-03-05
EP0732101A1 (en) 1996-09-18
MY110217A (en) 1998-03-31
DE69124875T2 (de) 1997-06-26

Similar Documents

Publication Publication Date Title
GR3031263T3 (en) Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
DE69304521D1 (de) Impfstoff Adjuvans
FI920324A7 (fi) Valmiste sellaisten vaikuttavien aineiden kontrolloituun vapautumiseen, jotka sopivat terapeuttisiksi aineiksi tai parantamaan kasvua ja ruoan hyväksikäyttöä märehtijöillä
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
DK0562705T3 (da) Anvendelse af L-deprenyl til fremstilling af et lægemiddel til behandling af Cushings sygdom
NO881735L (no) Skinnekjoeretoey med tverrhellingsinnretning.
DE3851456D1 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
EP0335704A3 (en) Treatment of equine livestock
DK0557755T3 (da) Måtte til husdyropdræt
IT8805215A0 (it) Girello per bambini con sistema di arresto in presenza di gradini o dislivelli.
KR880016581U (ko) 정수 및 살균장치가 장착된 가습기
ZA914219B (en) Transdermal administration to humans and animals
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants
ITMO910042A1 (it) Vibromassaggiatore per massaggiare il corpo umano.
DK627188A (da) Farmaceutisk komposition
ES556049A0 (es) Instalacion para la cria de conejos y de animales similares
FI941707L (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan
ZA892351B (en) Treatment of equine livestock
ITRM920698A0 (it) Dispositivo di facilitazione all'accesso ai letti di navi, traghetti e simili, per inabili
KR930004315U (ko) 보행기의 완충력을 겸한 정지장치
ITRM910300A0 (it) Dispositivo per generare - a scopo terapeutico - segnali di natura gravitazionale, che - a distanza - interferiscono col sistema nervoso umano e animale.
SE8700308L (sv) Dricksskal for pelsdjur och liknande for placering i/pa buren
RU96107604A (ru) Средство для повышения роста и сохранности ягнят
KR870014117U (ko) 해태망의 견인식 출몰장치
IT208459Z2 (it) Dispositivo per il trattamento diprodotti agricoli in grani